Board Meetings for REMUS

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
REMUSRemus Pharmaceuticals Limited20 May 2026Financial Results/Dividend/Other business mattersTo consider and approve the audited financial results for the period ended March 31, 2026, recommend final dividend, if any and other business matters
REMUSRemus Pharmaceuticals Limited20 May 2026Board Meeting IntimationREMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business.
REMUSRemus Pharmaceuticals Limited10 Nov 2025Board Meeting IntimationREMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Nov-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Dividend/Other business.
REMUSRemus Pharmaceuticals Limited10 Nov 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters
REMUSRemus Pharmaceuticals Limited17 May 2025Board Meeting IntimationREMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend/Other business.
REMUSRemus Pharmaceuticals Limited17 May 2025Financial Results/Dividend/Bonus/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025, dividend, bonus and other business matters
REMUSRemus Pharmaceuticals Limited17 May 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters
REMUSRemus Pharmaceuticals Limited09 Nov 2024Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024, interim dividend and other business matters
REMUSRemus Pharmaceuticals Limited09 Nov 2024Board Meeting IntimationREMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Dividend/Other business.
REMUSRemus Pharmaceuticals Limited16 May 2024REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 16-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business.Board Meeting Intimation
REMUSRemus Pharmaceuticals Limited16 May 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended March 31, 2024 and other business matters
REMUSRemus Pharmaceuticals Limited23 Apr 2024REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Apr-2024 to consider and approve Dividend/Bonus/Increase in authorised capital/Other business.Board Meeting Intimation
REMUSRemus Pharmaceuticals Limited22 Apr 2024Dividend/Other business mattersTo consider interim dividend for FY 2024-2025 and other business matters
REMUSRemus Pharmaceuticals Limited22 Apr 2024Dividend/Bonus/Other business mattersREMUS : 23-Apr-2024 : The Company has informed the Exchange that a Board meeting to be held on April 22, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 23, 2024, To consider Interim dividend , bonus and other business matters
REMUSRemus Pharmaceuticals Limited22 Apr 2024REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 22-Apr-2024 to consider and approve Dividend/Other business.Board Meeting Intimation
Showing page 1 of 2 (17 total items)
Next